Medicamen Biotech Ltd.
| BSE: 531146 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE646B01010 |
| BSE 00:00 | 24 Sep | 594.05 |
-18.00 (-2.94%) |
OPEN
618.00 |
HIGH
619.95 |
LOW
588.00 |
| NSE 05:30 | 01 Jan | Medicamen Biotech Ltd |
| OPEN | 618.00 |
| PREVIOUS CLOSE | 612.05 |
| VOLUME | 9990 |
| 52-Week high | 772.00 |
| 52-Week low | 355.00 |
| P/E | 49.92 |
| Mkt Cap.(Rs cr) | 726 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Medicamen Biotech Ltd. (MEDICAMENBIOTEC) - Company Information
Medicamen Biotech Ltd
Medicamen Biotech Ltd is a widely held Globally Recognized public limited company engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets. The company is engaged in manufacture and distribution of medicines. They manufacturer and supply the range of products such as tablets capsules liquid syrup and dry syrup (beta lactum and non beta lactum) and oint...> More
| COMPANY INFORMATION | |||||||
| Director : | Sanjay Bansal | ||||||
| Chairman : | Rahul Bishnoi | ||||||
| Director : | Ashwani Kumar Sharma | ||||||
| Independent Director : | Harish Pande | ||||||
| Director : | SURESH KUMAR SINGH | ||||||
| Independent Director : | Arun Kumar | ||||||
| Company Secretary : | Parul Choudhary | ||||||
| Independent Director : | Sumita Dwivedi | ||||||
| Addtnl Non-Executive Director : | Vimal Kumar Shrawat. | ||||||
| Addtnl Independent Director : | Sangeeta Bishnoi | ||||||
| Addtnl Independent Director : | Ravi Kumar Bansal | ||||||
| AUDITOR : | Rai Qimat & Associates | ||||||
| IND NAME : | Pharmaceuticals - Indian - Formulations | ||||||
| HOUSE NAME : | Indian Private | ||||||
| Registered office | |||||||
| 1506 Chiranjiv Tower 43, Nehru Place,New Delhi,New Delhi-110019 | |||||||
| Ph : 91-11-47589500 | |||||||
| WEBSITE : http://www.medicamen.com | |||||||
| E-mail : cs@medicamen.com | |||||||
Quick Links for Medicamen Biotech:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
